Division of Genetic Medicine and Clinical Pharmacology Archive — Page 4 of 12
-
May 1, 2024
VUMC’s Alexander Bick receives a ‘healthy aging’ research award
Vanderbilt's Alexander Bick, MD, PhD, has received a Hevolution/AFAR New Investigator Award in Aging Biology and Geroscience Research from the American Federation for Aging Research (AFAR) and Hevolution Foundation. -
May 1, 2024
Study finds 500 new blood pressure genes
An analysis of the genomes of more than 1 million people of European ancestry, conducted by several of the world’s leading genomic centers, including Vanderbilt University Medical Center, has identified more than 2,000 independent genetic signals for blood pressure. -
April 9, 2024
Heart disease, depression linked by inflammation: study
Coronary artery disease and major depression may be genetically linked via inflammatory pathways to an increased risk for cardiomyopathy, a degenerative heart muscle disease, researchers at Vanderbilt University Medical Center and Massachusetts General Hospital have found. -
March 27, 2024
Higher genetic risk of obesity means working out harder for same results
Study authors used activity, clinical and genetic data from the National Institutes of Health’s All of Us Research Program to explore the association of genetic risk of higher body mass index and the level of physical activity needed to reduce incident obesity. -
March 14, 2024
Pain medication. Cosmetics. Cleaning supplies. Tennessee Poison Center’s message: lock them away.
TPC’s help hotline —1-800-222-1222 — is staffed by nurses, pharmacists, physicians and board-certified medical toxicologists who are specially trained to assist callers. -
March 8, 2024
Douglas Ruderfer to direct new Center for Digital Genomic Medicine
Douglas Ruderfer, PhD, whose research at Vanderbilt University Medical Center explores the intersection of genomics, biomedical informatics and psychiatry, has been named director of a newly established Center for Digital Genomic Medicine. -
March 7, 2024
Study details metabolism of biomarkers for oxidative stress
Factors other than oxidative stress can modify the levels of biomarkers called isoprostanes that are commonly used in both experimental and clinical research, suggesting that additional standards need to be developed.